Cerevel Therapeutics
CERE
$40.74
Share price
0.25%
Change (1 day)
24.97%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) - Total assets
Total assets on the balance sheet as of March 2024 : $1.12 B
According to Cerevel Therapeutics's latest financial reports the company's total assets are $1.12 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Cerevel Therapeutics - Total assets on balance sheet (from 2020 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.24 B | 22.15% |
| 2022-12-31 | $1.01 B | 47.74% |
| 2021-12-31 | $0.68 B | 54.72% |
| 2020-12-31 | $0.44 B | 268.59% |
| 2019-12-31 | $0.12 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $54.83 B | 4,763.75% | 🇺🇸 USA |
 Campbell Soup CPB | $12.10 B | 973.86% | 🇺🇸 USA |
 Dow DOW | $58.81 B | 5,117.33% | 🇺🇸 USA |
 Dupont De Nemours DD | $37.71 B | 3,245.66% | 🇺🇸 USA |